Tips for Success As an Academic Clinical InvestigatorLEE, Stephanie J.Journal of clinical oncology. 2013, Vol 31, Num 6, pp 811-813, issn 0732-183X, 3 p.Article

Chronic myelogenous leukaemiaLEE, Stephanie J.British journal of haematology. 2000, Vol 111, Num 4, pp 993-1009, issn 0007-1048Article

Chronic myelogenous leukaemiaLEE, Stephanie J.British journal of haematology. 2000, Vol 111, Num 4, pp 993-1009, issn 0007-1048Article

New approaches for preventing and treating chronic graft-versus-host diseaseLEE, Stephanie J.Blood. 2005, Vol 105, Num 11, pp 4200-4206, issn 0006-4971, 7 p.Article

Risk factors for acute GVHD and survival after hematopoietic cell transplantationJAGASIA, Madan; ARORA, Mukta; ANTIN, Joseph H et al.Blood. 2012, Vol 119, Num 1, pp 296-307, issn 0006-4971, 12 p.Article

Direct-to-consumer advertising in oncology : A content analysis of print mediaABEL, Gregory A; LEE, Stephanie J; WEEKS, Jane C et al.Journal of clinical oncology. 2007, Vol 25, Num 10, pp 1267-1271, issn 0732-183X, 5 p.Article

Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trialLEE, Stephanie J; ZAHRIEH, David; SOIFFER, Robert J et al.Blood. 2004, Vol 104, Num 5, pp 1559-1564, issn 0006-4971, 6 p.Article

Physicians' attitudes about quality-of-life issues in hematopoietic stem cell transplantationLEE, Stephanie J; JOFFE, Steven; KIM, Haesook T et al.Blood. 2004, Vol 104, Num 7, pp 2194-2200, issn 0006-4971, 7 p.Article

Comparison of T-cell-depleted and non-T-cell-depleted unrelated donor transplantation for hematologic diseases: clinical outcomes, quality of life, and costsLEE, Stephanie J; ZAHRIEH, David; ALYEA, Edwin P et al.Blood. 2002, Vol 100, Num 8, pp 2697-2702, issn 0006-4971, 6 p.Article

Economics of hematopoietic cell transplantationKHERA, Nandita; ZELIADT, Steven B; LEE, Stephanie J et al.Blood. 2012, Vol 120, Num 8, pp 1545-1551, issn 0006-4971, 7 p.Article

Malignant hematologic diseases in adolescents and young adultsWOOD, William A; LEE, Stephanie J.Blood. 2011, Vol 117, Num 22, pp 5803-5815, issn 0006-4971, 13 p.Article

A disease risk index for patients undergoing allogeneic stem cell transplantationARMAND, Philippe; GIBSON, Christopher J; STORER, Barry E et al.Blood. 2012, Vol 120, Num 4, pp 905-913, issn 0006-4971, 9 p.Article

Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the Chronic Graft-versus-Host Disease ConsortiumPIDALA, Joseph; KURLAND, Brenda F; XIAOYU CHAI et al.Haematologica (Roma). 2011, Vol 96, Num 10, pp 1528-1535, issn 0390-6078, 8 p.Article

Private Cord Blood Banking : Experiences and Views of Pediatric Hematopoietic Cell Transplantation PhysiciansTHORNLEY, Ian; EAPEN, Mary; SUNG, Lillian et al.Pediatrics (Evanston). 2009, Vol 123, Num 3, pp 1011-1017, issn 0031-4005, 7 p.Article

Sentinel lymph node biopsy for evaluation and treatment of patients with merkel cell carcinoma : The dana-farber experience and meta-analysis of the literatureGUPTA, Sheela G; WANG, Linda C; PENAS, Pablo F et al.Archives of dermatology (1960). 2006, Vol 142, Num 6, pp 685-690, issn 0003-987X, 6 p.Article

Reduced frequency of FOXP3⁺ CD4⁺CD25⁺ regulatory T cells in patients with chronic graft-versus-host diseaseZORN, Emmanuel; KIM, Haesook T; RITZ, Jerome et al.Blood. 2005, Vol 106, Num 8, pp 2903-2911, issn 0006-4971, 9 p.Article

Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort studyMARTY, Francisco M; LEE, Stephanie J; FAHEY, Michelle M et al.Blood. 2003, Vol 102, Num 8, pp 2768-2776, issn 0006-4971, 9 p.Article

Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantationWADLEIGH, Martha; RICHARDSON, Paul G; DEANGELO, Daniel J et al.Blood. 2003, Vol 102, Num 5, pp 1578-1582, issn 0006-4971, 5 p.Article

Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantationANTIN, Joseph H; KIM, Haesook T; CUTLER, Corey et al.Blood. 2003, Vol 102, Num 5, pp 1601-1605, issn 0006-4971, 5 p.Article

Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium studyPIDALA, Joseph; VOGELSANG, Georgia; JACOBSOHN, David et al.Haematologica (Roma). 2012, Vol 97, Num 3, pp 451-458, issn 0390-6078, 8 p.Article

Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysisARORA, Mukta; KLEIN, John P; CAHN, Jean-Yves et al.Blood. 2011, Vol 117, Num 24, pp 6714-6720, issn 0006-4971, 7 p.Article

Effects of obstetric factors and storage temperatures on the yield of endothelial colony forming cells from umbilical cord bloodCOLDWELL, Kate E; LEE, Stephanie J; KEAN, Jennifer et al.Angiogenesis (London). 2011, Vol 14, Num 3, pp 381-392, issn 0969-6970, 12 p.Article

Outpatient management following intensive induction chemotherapy for myelodysplastic syndromes and acute myeloid leukemia: a pilot studyWALTER, Roland B; LEE, Stephanie J; GARDNER, Kelda M et al.Haematologica (Roma). 2011, Vol 96, Num 6, pp 914-917, issn 0390-6078, 4 p.Article

Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host diseaseJACOBSOHN, David A; ARORA, Mukta; CAHN, Jean-Yves et al.Blood. 2011, Vol 118, Num 16, pp 4472-4479, issn 0006-4971, 8 p.Article

Life Expectancy in Patients Surviving More Than 5 Years After Hematopoietic Cell TransplantationMARTIN, Paul J; COUNTS, George W; STORER, Barry E et al.Journal of clinical oncology. 2010, Vol 28, Num 6, pp 1011-1016, issn 0732-183X, 6 p.Article